BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30

• Drug Development

  Celgene International Sárl: Phase II Data Evaluating REVLIMID(R) + Rituximab in Relapsed Patients with Chronic Lymphocytic Leukaemia Presented at American Society of Hematology

  December 7, 2009

   · 

  1 min read
• Business

  Xencor Appoints Former ZymoGenetics, Inc. CEO, Bruce Carter, to Chairman of the Board

  December 7, 2009

   · 

  1 min read
• Drug Development

  PharmAthene, Inc. Presents Phase I Clinical Trial Results and New Therapeutic Animal Model Data for Protexia(R)

  December 7, 2009

   · 

  8 min read
• Biotech Bay

  Cytokinetics, Inc. Presents Non-Clinical Data Relating to CK-2017357 at the 5th Cachexia Conference

  December 7, 2009

   · 

  9 min read
• Drug Development

  Cytokinetics, Inc. Announces Clinical Trial Data Regarding SB-743921 Presented at the 2009 American Society of Hematology Annual Meeting and Exposition

  December 7, 2009

   · 

  7 min read
• Business

  Alexion Pharmaceuticals Inc.'s Soliris(R) Reversed Thrombocytopenia in Patients with Both PNH and Pre-Existing Thrombocytopenia in Study Presented at American Society of Hematology Annual Meeting

  December 7, 2009

   · 

  1 min read
• Drug Development

  Clavis Pharma ASA: Positive Phase II Clinical Data For Clavis Pharma’s Elacytarabine Presented At American Society of Hematology Annual Meeting

  December 7, 2009

   · 

  9 min read
• Bio NC

  Becton, Dickinson and Company Expands Diagnostic Testing Offerings in Women’s Health

  December 7, 2009

   · 

  2 min read
• Business

  Novo Nordisk A/S Starts Phase 1 Trial With Oral Insulin Analogue -- Merrion Pharmaceuticals, Inc. Earns USD 2 Million Milestone Payment

  December 7, 2009

   · 

  1 min read
• Allos Therapeutics, Inc.’ FOLOTYN(TM) Demonstrates Activity in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma Treated with Stem Cell Transplant

  December 7, 2009

   · 

  1 min read